Letters Antimicrobial resistance

Incentives for developing new antibiotics or antimicrobial strategies

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2136 (Published 08 April 2013) Cite this as: BMJ 2013;346:f2136
  1. Ulf R Dahle, department director1,
  2. Fernanda C Petersen, associate professor2
  1. 1Norwegian Institute of Public Health, 0403 Oslo, Norway
  2. 2Department of Oral Biology, Faculty of Dentistry, University of Oslo, Norway
  1. ulf.dahle{at}fhi.no

Neonatal mortality approaches 50% in parts of Norway, cholera and typhoid fever force families to abandon their homes, parts of cities are quarantined. Tuberculosis mortality is 400/100 000 and 50% of children are absent from school. These were Norwegian statistics 100 years ago.1 The focus on antimicrobial resistance is highly relevant.2 If infections reach such proportions again, resistance …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial